Pharmaceutical Technology: Developing an oral Covid-19 vaccine

Pharmaceutical Technology looks at how Oramed Pharmaceuticals has teamed up with Premas Biotech to develop an alternative to injectable Covid-19 vaccines.  Together, the companies have merged to form a joint venture focused on the development of Covid-19 vaccines called Oravax Medical, combining Oramed’s proprietary POD oral delivery technology and Premas’ novel vaccine technology. To read more click here.

You may also be interested

Join our mailing list

Skip to content